The use of epidermal growth factor in dermatological practice

Epidermal growth factor (EGF) is a growth factor that plays a pivotal role in wound healing and maintaining tissue homeostasis by regulating cell survival, proliferation, migration, and differentiation. Exogenous administration of bioidentical human recombinant epidermal growth factor (rhEGF) has be...

Full description

Saved in:
Bibliographic Details
Published inInternational wound journal Vol. 20; no. 6; pp. 2414 - 2423
Main Authors Shin, Sun Hye, Koh, Young Gue, Lee, Woo Geon, Seok, Joon, Park, Kui Young
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.08.2023
John Wiley & Sons, Inc
Subjects
Acne
Allergens
Cancer therapies
Cell growth
Chemotherapy
Clinical trials
cosmetics
Cytokines
Dermatitis
dermatology
Diabetes
Drug delivery systems
Epidermal growth factor
Erythema
Fibroblasts
Foot diseases
Inflammation
Leg ulcers
Quality of life
Radiation therapy
Review
Scars
Skin
Tumorigenesis
wound
Wound healing
wound
dermatology
epidermal growth factor
cosmetics
Online AccessGet full text
ISSN1742-4801
1742-481X
1742-481X
DOI10.1111/iwj.14075

Cover

Abstract Epidermal growth factor (EGF) is a growth factor that plays a pivotal role in wound healing and maintaining tissue homeostasis by regulating cell survival, proliferation, migration, and differentiation. Exogenous administration of bioidentical human recombinant epidermal growth factor (rhEGF) has been known to promote skin wound healing, although rhEGF is increasingly being used in drug delivery systems and nanotechnology. However, despite considerable attention being focused on the potential clinical applications of rhEGF in several dermatological conditions beyond wound healing, the number of studies still remains relatively low. Herein, we conducted a literature search of PubMed/Medline and Google Scholar databases to retrieve published literature related to rhEGF and summarised the effects of rhEGF in the treatment of various wound types, radiotherapy or chemotherapy‐related skin reactions, atopic dermatitis, skin aging, and post‐inflammatory hyperpigmentation.
AbstractList Epidermal growth factor (EGF) is a growth factor that plays a pivotal role in wound healing and maintaining tissue homeostasis by regulating cell survival, proliferation, migration, and differentiation. Exogenous administration of bioidentical human recombinant epidermal growth factor (rhEGF) has been known to promote skin wound healing, although rhEGF is increasingly being used in drug delivery systems and nanotechnology. However, despite considerable attention being focused on the potential clinical applications of rhEGF in several dermatological conditions beyond wound healing, the number of studies still remains relatively low. Herein, we conducted a literature search of PubMed/Medline and Google Scholar databases to retrieve published literature related to rhEGF and summarised the effects of rhEGF in the treatment of various wound types, radiotherapy or chemotherapy-related skin reactions, atopic dermatitis, skin aging, and post-inflammatory hyperpigmentation.Epidermal growth factor (EGF) is a growth factor that plays a pivotal role in wound healing and maintaining tissue homeostasis by regulating cell survival, proliferation, migration, and differentiation. Exogenous administration of bioidentical human recombinant epidermal growth factor (rhEGF) has been known to promote skin wound healing, although rhEGF is increasingly being used in drug delivery systems and nanotechnology. However, despite considerable attention being focused on the potential clinical applications of rhEGF in several dermatological conditions beyond wound healing, the number of studies still remains relatively low. Herein, we conducted a literature search of PubMed/Medline and Google Scholar databases to retrieve published literature related to rhEGF and summarised the effects of rhEGF in the treatment of various wound types, radiotherapy or chemotherapy-related skin reactions, atopic dermatitis, skin aging, and post-inflammatory hyperpigmentation.
Epidermal growth factor (EGF) is a growth factor that plays a pivotal role in wound healing and maintaining tissue homeostasis by regulating cell survival, proliferation, migration, and differentiation. Exogenous administration of bioidentical human recombinant epidermal growth factor (rhEGF) has been known to promote skin wound healing, although rhEGF is increasingly being used in drug delivery systems and nanotechnology. However, despite considerable attention being focused on the potential clinical applications of rhEGF in several dermatological conditions beyond wound healing, the number of studies still remains relatively low. Herein, we conducted a literature search of PubMed/Medline and Google Scholar databases to retrieve published literature related to rhEGF and summarised the effects of rhEGF in the treatment of various wound types, radiotherapy or chemotherapy‐related skin reactions, atopic dermatitis, skin aging, and post‐inflammatory hyperpigmentation.
Author Lee, Woo Geon
Park, Kui Young
Shin, Sun Hye
Seok, Joon
Koh, Young Gue
AuthorAffiliation 1 Department of Dermatology Chung‐Ang University College of Medicine Seoul South Korea
AuthorAffiliation_xml – name: 1 Department of Dermatology Chung‐Ang University College of Medicine Seoul South Korea
Author_xml – sequence: 1
  givenname: Sun Hye
  orcidid: 0000-0002-0479-8174
  surname: Shin
  fullname: Shin, Sun Hye
  organization: Chung‐Ang University College of Medicine
– sequence: 2
  givenname: Young Gue
  surname: Koh
  fullname: Koh, Young Gue
  organization: Chung‐Ang University College of Medicine
– sequence: 3
  givenname: Woo Geon
  surname: Lee
  fullname: Lee, Woo Geon
  organization: Chung‐Ang University College of Medicine
– sequence: 4
  givenname: Joon
  surname: Seok
  fullname: Seok, Joon
  organization: Chung‐Ang University College of Medicine
– sequence: 5
  givenname: Kui Young
  orcidid: 0000-0001-5965-1754
  surname: Park
  fullname: Park, Kui Young
  email: kyky@cauhs.or.kr
  organization: Chung‐Ang University College of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36584669$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtLAzEUhYNUfFQX_gEZcKOLqclk8lqISPFJwU1FdyGTZtqU6aQmMxb_vWmrRQXNJuGe7x7uzdkHndrVBoAjBHsonnO7mPZQDhnZAnuI5Vmac_TS2bwh2gX7IUwhzAQhbAfsYkp4TqnYAxfDiUnaYBJXJmZuR8bPVJWMvVs0k6RUunE-sXWyqjeucmOroz73UbHaHIDtUlXBHH7eXfB0cz3s36WDx9v7_tUg1YTmJKWaES1Ko1XOOC4Zz0quoEKMCFwQSAqkGOVClQwixk1RjKgQGFGRc1owpHEXXK59520xMyNt6sarSs69nSn_Lp2y8qdS24kcuzeJIMYYZjQ6nH46ePfamtDImQ3aVJWqjWuDzOIsgmYMLtGTX-jUtb6O-0kMBaSQI4Iidfx9pM0sX18bgbM1oL0LwZtygyAol7HJGJtcxRbZ81-sto1qrFtuY6v_Oha2Mu9_W8v754d1xwc_J6fa
CitedBy_id crossref_primary_10_4236_jdm_2024_144016
crossref_primary_10_1016_j_biopha_2024_117470
crossref_primary_10_3390_gels10060370
crossref_primary_10_7717_peerj_17957
crossref_primary_10_1016_j_biopha_2023_115437
crossref_primary_10_1097_IOP_0000000000002765
crossref_primary_10_1111_jocd_16552
crossref_primary_10_1016_j_ijbiomac_2024_136452
crossref_primary_10_1111_jcpe_14073
crossref_primary_10_1016_j_glmedi_2024_100163
crossref_primary_10_1007_s00784_025_06189_5
crossref_primary_10_1016_j_jgr_2024_09_006
crossref_primary_10_3390_cosmetics11060198
crossref_primary_10_3390_cimb46020102
crossref_primary_10_1016_j_biomaterials_2024_122802
crossref_primary_10_1016_j_jddst_2024_105722
crossref_primary_10_7717_peerj_17806
crossref_primary_10_3389_fmed_2024_1384500
crossref_primary_10_3390_cancers17050787
crossref_primary_10_3390_cosmetics11010010
crossref_primary_10_12677_acm_2024_14112841
crossref_primary_10_1016_j_ijbiomac_2024_133251
crossref_primary_10_3390_jcm13082287
crossref_primary_10_7759_cureus_48943
crossref_primary_10_1016_j_ijbiomac_2025_140659
crossref_primary_10_3390_foods14060996
crossref_primary_10_1002_cbin_12221
crossref_primary_10_3390_ijms241713091
crossref_primary_10_1002_ddr_22234
crossref_primary_10_3390_ijms241512450
crossref_primary_10_1007_s00403_024_02824_5
crossref_primary_10_1016_j_mtcomm_2023_107051
crossref_primary_10_21518_akh2024_043
crossref_primary_10_1016_j_jbiosc_2024_10_011
Cites_doi 10.1111/wrr.12187
10.1111/j.1742-481X.2007.00332.x
10.1042/bj2470385
10.1097/01.DSS.0000450924.44391.d2
10.3109/09546634.2014.906034
10.1111/ijd.12488
10.1172/JCI128678
10.1007/s11095-012-0729-1
10.1089/scd.2016.0234
10.1016/S0092-8674(02)00963-7
10.3390/cancers12113120
10.1111/j.1742-481X.2011.00895.x
10.3390/medicina57020166
10.5021/ad.2018.30.1.54
10.1177/1534734616645444
10.2174/1389201023378229
10.1111/jocd.12855
10.1111/j.1524-4725.2006.32354.x
10.7314/APJCP.2013.14.8.4859
10.3857/roj.2014.32.3.156
10.1269/jrr.09066
10.1242/dev.031427
10.1097/DSS.0000000000000197
10.1038/nrc1970
10.1172/JCI116130
10.3390/ph13080167
10.4103/0976-9668.136160
10.1007/s00403-014-1463-9
10.1016/j.tjog.2021.03.014
10.1111/jocd.12691
10.4172/2157-2518.1000115
10.5021/ad.2017.29.2.187
10.1111/j.1742-481X.2009.00622.x
10.1111/j.1524-475X.2010.00612.x
10.1159/000445630
10.4142/jvs.2006.7.2.105
10.1634/theoncologist.2019-0221
10.1016/j.jdermsci.2014.04.011
10.5021/ad.2019.31.3.263
10.1111/j.1742-481X.2009.00584.x
10.1016/S0925-4773(01)00452-X
10.1016/S0021-9258(19)83739-0
10.1016/j.actbio.2017.11.045
10.1111/exd.12182
10.4049/jimmunol.1301062
10.1155/2018/9439182
10.1074/jbc.M212082200
10.1111/bjd.13954
10.1111/exd.14638
10.1080/09546634.2018.1468546
10.1111/dsu.12348
10.5021/ad.2021.33.6.549
10.1269/jrr.10010
10.4103/ijt.ijt_51_20
10.1159/000521294
10.1016/j.burns.2019.12.015
10.3892/ijmm.2015.2088
10.1038/s41598-018-30404-x
10.1016/j.diabres.2018.06.002
10.1021/acs.biomac.6b01216
10.1111/1523-1747.ep12371760
10.1111/exd.12921
ContentType Journal Article
Copyright 2022 The Authors. published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.
2022 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.
2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022 The Authors. published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.
– notice: 2022 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.
– notice: 2023. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
NAPCQ
PHGZM
PHGZT
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOI 10.1111/iwj.14075
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
PubMed

ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Proquest Health and Medical Complete
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Shin et al
EISSN 1742-481X
EndPage 2423
ExternalDocumentID PMC10333026
36584669
10_1111_iwj_14075
IWJ14075
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OC
24P
29J
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6PF
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANHP
AAONW
AAWTL
AAZKR
ABCQN
ABCUV
ABEML
ABPVW
ABUWG
ACBWZ
ACCFJ
ACCMX
ACGFO
ACGFS
ACMXC
ACPOU
ACRPL
ACSCC
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADPDF
ADXAS
ADZMN
ADZOD
AEEZP
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFGKR
AFKRA
AFPWT
AIAGR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVUZU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYUFA
G-S
G.N
GODZA
GROUPED_DOAJ
H.X
HF~
HMCUK
HVGLF
HZ~
IAO
IHE
IHR
INH
IX1
J0M
LATKE
LC2
LC3
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NAPCQ
NF~
O66
O9-
OIG
OK1
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RPM
RX1
SUPJJ
TEORI
UB1
UKHRP
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WQ9
WQJ
WRC
WVDHM
WXI
XG1
YCJ
ZZTAW
~IA
~WT
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
NPM
PPXIY
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQQKQ
PQUKI
WIN
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c5645-6c75c9feca4783f782f8a0a17593b505b1a7689af70178ebbd6993169486b71c3
IEDL.DBID DR2
ISSN 1742-4801
1742-481X
IngestDate Thu Aug 21 18:36:58 EDT 2025
Fri Sep 05 06:41:03 EDT 2025
Wed Aug 13 08:30:49 EDT 2025
Mon Jul 21 06:00:38 EDT 2025
Thu Apr 24 22:56:46 EDT 2025
Tue Jul 01 05:05:14 EDT 2025
Wed Jan 22 16:21:42 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords wound
dermatology
epidermal growth factor
cosmetics
Language English
License Attribution-NonCommercial-NoDerivs
2022 The Authors. International Wound Journal published by Medicalhelplines.com Inc (3M) and John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5645-6c75c9feca4783f782f8a0a17593b505b1a7689af70178ebbd6993169486b71c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-0479-8174
0000-0001-5965-1754
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fiwj.14075
PMID 36584669
PQID 3090608151
PQPubID 6860429
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10333026
proquest_miscellaneous_2759962706
proquest_journals_3090608151
pubmed_primary_36584669
crossref_primary_10_1111_iwj_14075
crossref_citationtrail_10_1111_iwj_14075
wiley_primary_10_1111_iwj_14075_IWJ14075
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2023
PublicationDateYYYYMMDD 2023-08-01
PublicationDate_xml – month: 08
  year: 2023
  text: August 2023
PublicationDecade 2020
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: Oxford
PublicationTitle International wound journal
PublicationTitleAlternate Int Wound J
PublicationYear 2023
Publisher Blackwell Publishing Ltd
John Wiley & Sons, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: John Wiley & Sons, Inc
References 2015; 35
2013; 22
2002; 110
2010; 18
2006; 32
2019; 18
2020; 13
2020; 12
2016; 39
2001; 107
2003; 278
2012; 11
2014; 22
1962; 237
2015; 173
1992; 90
1994; 102
2018; 8
2014; 5
2013; 14
2010; 24
2021; 33
2020; 130
2009; 50
2015; 41
2012; 29
2007; 4
2018; 30
2022; 31
2014; 53
2021; 47
2018; 142
2010; 34
2015; 14
2017; 26
2019; 31
2019; 30
1987; 247
2006; 7
2002; 3
2006; 6
2017; 29
2014; 192
2018; 66
2016; 17
2014; 40
2022; 238
2016; 15
2009; 136
2014; 306
2021; 57
2015; 26
2018; 17
2018; 2018
2013; 39
2017; 16
2020; 25
2011; 02
2009; 6
2021; 60
2016; 25
2010; 51
2014; 32
2012; 9
2014; 75
e_1_2_12_4_1
e_1_2_12_6_1
e_1_2_12_19_1
e_1_2_12_2_1
e_1_2_12_17_1
e_1_2_12_38_1
Schouest JM (e_1_2_12_62_1) 2012; 11
e_1_2_12_20_1
e_1_2_12_41_1
e_1_2_12_66_1
e_1_2_12_64_1
e_1_2_12_45_1
e_1_2_12_26_1
e_1_2_12_47_1
e_1_2_12_68_1
Stoddard MA (e_1_2_12_44_1) 2017; 16
e_1_2_12_60_1
e_1_2_12_28_1
e_1_2_12_49_1
Guo X (e_1_2_12_24_1) 2010; 24
e_1_2_12_31_1
e_1_2_12_52_1
e_1_2_12_33_1
e_1_2_12_54_1
e_1_2_12_35_1
e_1_2_12_56_1
e_1_2_12_37_1
e_1_2_12_58_1
e_1_2_12_14_1
e_1_2_12_12_1
e_1_2_12_8_1
e_1_2_12_10_1
e_1_2_12_50_1
e_1_2_12_3_1
e_1_2_12_5_1
e_1_2_12_18_1
e_1_2_12_16_1
e_1_2_12_39_1
e_1_2_12_42_1
e_1_2_12_65_1
e_1_2_12_21_1
e_1_2_12_63_1
e_1_2_12_23_1
e_1_2_12_46_1
Cho KH (e_1_2_12_22_1) 2010; 34
e_1_2_12_25_1
e_1_2_12_48_1
e_1_2_12_67_1
e_1_2_12_61_1
e_1_2_12_40_1
e_1_2_12_27_1
e_1_2_12_29_1
e_1_2_12_30_1
e_1_2_12_53_1
e_1_2_12_32_1
e_1_2_12_55_1
e_1_2_12_34_1
e_1_2_12_57_1
e_1_2_12_36_1
e_1_2_12_59_1
e_1_2_12_15_1
e_1_2_12_13_1
Seidel R (e_1_2_12_43_1) 2015; 14
e_1_2_12_11_1
e_1_2_12_7_1
e_1_2_12_51_1
e_1_2_12_9_1
References_xml – volume: 16
  start-page: 322
  issue: 4
  year: 2017
  end-page: 326
  article-title: Improvement of atrophic acne scars in skin of color using topical synthetic epidermal growth factor (EGF) serum: a pilot study
  publication-title: J Drugs Dermatol
– volume: 32
  start-page: 1458
  issue: 12
  year: 2006
  end-page: 1466
  article-title: Postacne scarring: a qualitative global scarring grading system
  publication-title: Dermatol Surg
– volume: 247
  start-page: 385
  issue: 2
  year: 1987
  end-page: 388
  article-title: Epidermal growth factor increases collagen production in granulation tissue by stimulation of fibroblast proliferation and not by activation of procollagen genes
  publication-title: Biochem J
– volume: 51
  start-page: 511
  issue: 5
  year: 2010
  end-page: 517
  article-title: The preventive effect of recombinant human growth factor (rhEGF) on the recurrence of radiodermatitis
  publication-title: J Radiat Res
– volume: 39
  start-page: 360
  issue: 1
  year: 2016
  end-page: 370
  article-title: Epidermal growth factor promotes proliferation and migration of follicular outer root sheath cells via Wnt/beta‐catenin signaling
  publication-title: Cell Physiol Biochem
– volume: 12
  start-page: 182
  issue: 4
  year: 2020
  end-page: 187
  article-title: More is not always better in hair growth factors. Epidermal growth factor: hair growth factor involved in alopecia areata pathogenesis
  publication-title: Int J Trichology
– volume: 15
  start-page: 120
  issue: 2
  year: 2016
  end-page: 125
  article-title: Efficacy of topical recombinant human epidermal growth factor for treatment of diabetic foot ulcer: a systematic review and meta‐analysis
  publication-title: Int J Low Extrem Wounds
– volume: 8
  start-page: 11895
  issue: 1
  year: 2018
  article-title: Topical administration of EGF suppresses immune response and protects skin barrier in DNCB‐induced atopic dermatitis in NC/Nga mice
  publication-title: Sci Rep
– volume: 26
  start-page: 159
  issue: 2
  year: 2015
  end-page: 164
  article-title: Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients
  publication-title: J Dermatolog Treat
– volume: 30
  start-page: 54
  issue: 1
  year: 2018
  end-page: 63
  article-title: Epidermal growth factor attenuated the expression of inflammatory cytokines in human epidermal keratinocyte exposed to Propionibacterium acnes
  publication-title: Ann Dermatol.
– volume: 30
  start-page: 96
  issue: 1
  year: 2019
  end-page: 101
  article-title: Human recombinant epidermal growth factor in skin lesions: 77 cases in EPItelizando project
  publication-title: J Dermatolog Treat
– volume: 90
  start-page: 2392
  issue: 6
  year: 1992
  end-page: 2401
  article-title: Epidermal growth factor receptor distribution in burn wounds. Implications for growth factor‐mediated repair
  publication-title: J Clin Invest
– volume: 24
  start-page: 462
  issue: 4
  year: 2010
  end-page: 464
  article-title: Clinical study on repair of burn wounds of degree II with recombinant human epidermal growth factor in elderly patients
  publication-title: Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
– volume: 18
  start-page: 1539
  year: 2019
  end-page: 1545
  article-title: Increased synthesis of hyaluronic acid by enhanced penetration of CTP‐EGF recombinant in human keratinocytes
  publication-title: J Cosmet Dermatol
– volume: 142
  start-page: 335
  year: 2018
  end-page: 344
  article-title: Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: a phase III multicenter, double‐blind, randomized, placebo‐controlled trial
  publication-title: Diabetes Res Clin Pract
– volume: 130
  start-page: 1417
  issue: 3
  year: 2020
  end-page: 1430
  article-title: IL‐36gamma drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
  publication-title: J Clin Invest
– volume: 33
  start-page: 549
  issue: 6
  year: 2021
  end-page: 552
  article-title: Effect of the recombinant human epidermal growth factor ointment on cutaneous surgical wounds compared to antibiotic ointment
  publication-title: Ann Dermatol
– volume: 12
  start-page: 3120
  issue: 11
  year: 2020
  article-title: rhEGF treatment improves EGFR inhibitor‐induced skin barrier and immune defects
  publication-title: Cancers (Basel)
– volume: 41
  start-page: 131
  issue: 1
  year: 2015
  end-page: 135
  article-title: Effect of an epidermal growth factor‐containing cream on postinflammatory hyperpigmentation after Q‐switched 532‐nm neodymium‐doped yttrium aluminum garnet laser treatment
  publication-title: Dermatol Surg
– volume: 5
  start-page: 273
  issue: 2
  year: 2014
  end-page: 277
  article-title: Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's grade 1 and 2 diabetic foot ulcers: comparative analysis of 50 patients
  publication-title: J Nat Sci Biol Med
– volume: 22
  start-page: 496
  issue: 7
  year: 2013
  end-page: 499
  article-title: Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy‐induced alopecia
  publication-title: Exp Dermatol
– volume: 306
  start-page: 635
  issue: 7
  year: 2014
  end-page: 643
  article-title: Treatment with low‐temperature atmospheric pressure plasma enhances cutaneous delivery of epidermal growth factor by regulating E‐cadherin‐mediated cell junctions
  publication-title: Arch Dermatol Res
– volume: 102
  start-page: 186
  issue: 2
  year: 1994
  end-page: 191
  article-title: Effects of EGF on the morphology and patterns of DNA synthesis in isolated human hair follicles
  publication-title: J Invest Dermatol
– volume: 35
  start-page: 1017
  issue: 4
  year: 2015
  end-page: 1025
  article-title: Epidermal growth factor improves the migration and contractility of aged fibroblasts cultured on 3D collagen matrices
  publication-title: Int J Mol Med
– volume: 107
  start-page: 69
  issue: 1–2
  year: 2001
  end-page: 82
  article-title: Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of sonic hedgehog in hair follicle morphogenesis
  publication-title: Mech Dev
– volume: 136
  start-page: 2153
  issue: 13
  year: 2009
  end-page: 2164
  article-title: KGF and EGF signalling block hair follicle induction and promote interfollicular epidermal fate in developing mouse skin
  publication-title: Development
– volume: 32
  start-page: 156
  issue: 3
  year: 2014
  end-page: 162
  article-title: The safety and efficacy of EGF‐based cream for the prevention of radiotherapy‐induced skin injury: results from a multicenter observational study
  publication-title: Radiat Oncol J
– volume: 2018
  start-page: 9439182
  year: 2018
  end-page: 9439189
  article-title: Epidermal growth factor relieves inflammatory signals in Staphylococcus aureus‐treated human epidermal keratinocytes and atopic dermatitis‐like skin lesions in Nc/Nga mice
  publication-title: Biomed Res Int
– volume: 47
  start-page: 643
  issue: 3
  year: 2021
  end-page: 653
  article-title: Efficacy and safety of nano‐silver dressings combined with recombinant human epidermal growth factor for deep second‐degree burns: a meta‐analysis
  publication-title: Burns
– volume: 6
  start-page: 803
  issue: 10
  year: 2006
  end-page: 812
  article-title: Mechanisms of cutaneous toxicities to EGFR inhibitors
  publication-title: Nat Rev Cancer
– volume: 40
  start-page: 706
  issue: 6
  year: 2014
  end-page: 708
  article-title: Using recombinant human epidermal growth factor for the successful treatment of an excisional wound without a primary closure
  publication-title: Dermatol Surg
– volume: 3
  start-page: 361
  issue: 4
  year: 2002
  end-page: 371
  article-title: The stability factor: importance in formulation development
  publication-title: Curr Pharm Biotechnol
– volume: 34
  start-page: 253
  issue: 3
  year: 2010
  end-page: 258
  article-title: Therapeutic effect of the recombinant human epidermal growth factor (rhEGF) in pressure ulcer
  publication-title: Journal of the Korean Academy of Rehabilitation Medicine
– volume: 4
  start-page: 216
  issue: 3
  year: 2007
  end-page: 220
  article-title: The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer
  publication-title: Int Wound J
– volume: 66
  start-page: 325
  year: 2018
  end-page: 334
  article-title: Effects of structurally stabilized EGF and bFGF on wound healing in type I and type II diabetic mice
  publication-title: Acta Biomater
– volume: 14
  start-page: 1005
  issue: 9
  year: 2015
  end-page: 1010
  article-title: Improvement in atrophic acne scars using topical synthetic epidermal growth factor (EGF) serum: a pilot study
  publication-title: J Drugs Dermatol
– volume: 110
  start-page: 775
  issue: 6
  year: 2002
  end-page: 787
  article-title: Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains
  publication-title: Cell
– volume: 13
  start-page: 167
  issue: 8
  year: 2020
  article-title: Evolution of nanotechnology in delivering drugs to eyes, skin and wounds via topical route
  publication-title: Pharmaceuticals (Basel)
– volume: 29
  start-page: 2017
  issue: 7
  year: 2012
  end-page: 2029
  article-title: Enhanced topical delivery of small hydrophilic or lipophilic active agents and epidermal growth factor by fractional radiofrequency microporation
  publication-title: Pharm Res
– volume: 18
  start-page: 499
  issue: 5
  year: 2010
  end-page: 505
  article-title: Nanotechnology promotes the full‐thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats
  publication-title: Wound Repair Regen
– volume: 17
  start-page: 3694
  issue: 11
  year: 2016
  end-page: 3705
  article-title: Hyaluronate‐epidermal growth factor conjugate for skin wound healing and regeneration
  publication-title: Biomacromolecules
– volume: 6
  start-page: 331
  issue: 5
  year: 2009
  end-page: 346
  article-title: Epidermal growth factor in clinical practice ‐ a review of its biological actions, clinical indications and safety implications
  publication-title: Int Wound J
– volume: 25
  start-page: e186
  issue: 1
  year: 2020
  end-page: e193
  article-title: A randomized controlled trial of epidermal growth factor ointment for treating epidermal growth factor receptor inhibitor‐induced skin toxicities
  publication-title: Oncologist
– volume: 75
  start-page: 94
  issue: 2
  year: 2014
  end-page: 99
  article-title: Epidermal growth factor receptor inhibitors selectively inhibit the expressions of human beta‐defensins induced by Staphylococcus epidermidis
  publication-title: J Dermatol Sci
– volume: 17
  start-page: 756
  issue: 5
  year: 2018
  end-page: 761
  article-title: The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: a split‐face randomized controlled study
  publication-title: J Cosmet Dermatol
– volume: 6
  start-page: 107
  issue: 2
  year: 2009
  end-page: 115
  article-title: Epidermal growth factor‐containing wound closure enhances wound healing in non‐diabetic and diabetic rats
  publication-title: Int Wound J
– volume: 60
  start-page: 468
  issue: 3
  year: 2021
  end-page: 473
  article-title: Microencapsulated rhEGF to facilitate epithelial healing and prevent scar formation of cesarean wound: a randomized controlled trial
  publication-title: Taiwan J Obstet Gynecol
– volume: 11
  start-page: 613
  issue: 5
  year: 2012
  end-page: 620
  article-title: Improved texture and appearance of human facial skin after daily topical application of barley produced, synthetic, human‐like epidermal growth factor (EGF) serum
  publication-title: J Drugs Dermatol
– volume: 39
  start-page: 1903
  issue: 12
  year: 2013
  end-page: 1911
  article-title: Epidermal growth factor and epidermal growth factor signaling attenuate laser‐induced melanogenesis
  publication-title: Dermatol Surg
– volume: 02
  start-page: 1
  year: 2011
  end-page: 14
  article-title: Epidermal growth factor (EGF) and platelet‐derived growth factor (PDGF) as tissue healing agents: clarifying concerns about their possible role in malignant transformation and tumor progression
  publication-title: Journal of Carcinogenesis & Mutagenesis
– volume: 278
  start-page: 26120
  issue: 28
  year: 2003
  end-page: 26126
  article-title: Epidermal growth factor as a biologic switch in hair growth cycle
  publication-title: J Biol Chem
– volume: 192
  start-page: 859
  issue: 3
  year: 2014
  end-page: 866
  article-title: EGFR signaling blunts allergen‐induced IL‐6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis
  publication-title: J Immunol
– volume: 7
  start-page: 105
  issue: 2
  year: 2006
  end-page: 109
  article-title: Topical application of epidermal growth factor accelerates wound healing by myofibroblast proliferation and collagen synthesis in rat
  publication-title: J Vet Sci
– volume: 238
  start-page: 837
  issue: 5
  year: 2022
  end-page: 845
  article-title: Clinical and histological effects of topical epidermal growth factor on acne and acne scars
  publication-title: Dermatology
– volume: 57
  year: 2021
– volume: 237
  start-page: 1555
  year: 1962
  end-page: 1562
  article-title: Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new‐born animal
  publication-title: J Biol Chem
– volume: 50
  start-page: 545
  issue: 6
  year: 2009
  end-page: 552
  article-title: Recombinant human epidermal growth factor accelerates the proliferation of irradiated human fibroblasts and keratinocytes in vitro and in vivo
  publication-title: J Radiat Res
– volume: 53
  start-page: 1031
  issue: 8
  year: 2014
  end-page: 1036
  article-title: Topical epidermal growth factor for the improvement of acne lesions: a randomized, double‐blinded, placebo‐controlled, split‐face trial
  publication-title: Int J Dermatol
– volume: 31
  start-page: 263
  issue: 3
  year: 2019
  end-page: 271
  article-title: Anti‐wrinkle efficacy of cross‐linked hyaluronic acid‐based microneedle patch with acetyl Hexapeptide‐8 and epidermal growth factor on Korean skin
  publication-title: Ann Dermatol.
– volume: 14
  start-page: 4859
  issue: 8
  year: 2013
  end-page: 4864
  article-title: Topical use of recombinant human epidermal growth factor (EGF)‐based cream to prevent radiation dermatitis in breast cancer patients: a single‐blind randomized preliminary study
  publication-title: Asian Pac J Cancer Prev
– volume: 31
  start-page: 1685
  year: 2022
  end-page: 1692
  article-title: Rheological properties and preclinical data of novel hyaluronic acid filler containing epidermal growth factor
  publication-title: Exp Dermatol
– volume: 25
  start-page: 275
  issue: 4
  year: 2016
  end-page: 281
  article-title: The epidermal growth factor receptor decreases Stathmin 1 and triggers catagen entry in the mouse
  publication-title: Exp Dermatol
– volume: 29
  start-page: 187
  issue: 2
  year: 2017
  end-page: 193
  article-title: The effect of micro‐spicule containing epidermal growth factor on periocular wrinkles
  publication-title: Ann Dermatol.
– volume: 22
  start-page: 497
  issue: 4
  year: 2014
  end-page: 503
  article-title: Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double‐blinded controlled trial
  publication-title: Wound Repair Regen
– volume: 26
  start-page: 113
  issue: 2
  year: 2017
  end-page: 122
  article-title: Epidermal growth factor induces proliferation of hair follicle‐derived mesenchymal stem cells through epidermal growth factor receptor‐mediated activation of ERK and AKT signaling pathways associated with upregulation of cyclin D1 and downregulation of p16
  publication-title: Stem Cells Dev
– volume: 173
  start-page: 370
  issue: 2
  year: 2015
  end-page: 378
  article-title: Cellular and molecular mechanisms of repair in acute and chronic wound healing
  publication-title: Br J Dermatol
– volume: 9
  start-page: 362
  issue: 4
  year: 2012
  end-page: 371
  article-title: Oxidant and antioxidant events during epidermal growth factor therapy to cutaneous wound healing in rats
  publication-title: Int Wound J
– ident: e_1_2_12_19_1
  doi: 10.1111/wrr.12187
– ident: e_1_2_12_31_1
  doi: 10.1111/j.1742-481X.2007.00332.x
– ident: e_1_2_12_17_1
  doi: 10.1042/bj2470385
– ident: e_1_2_12_27_1
  doi: 10.1097/01.DSS.0000450924.44391.d2
– ident: e_1_2_12_28_1
  doi: 10.3109/09546634.2014.906034
– ident: e_1_2_12_42_1
  doi: 10.1111/ijd.12488
– ident: e_1_2_12_39_1
  doi: 10.1172/JCI128678
– ident: e_1_2_12_12_1
  doi: 10.1007/s11095-012-0729-1
– ident: e_1_2_12_53_1
  doi: 10.1089/scd.2016.0234
– volume: 14
  start-page: 1005
  issue: 9
  year: 2015
  ident: e_1_2_12_43_1
  article-title: Improvement in atrophic acne scars using topical synthetic epidermal growth factor (EGF) serum: a pilot study
  publication-title: J Drugs Dermatol
– volume: 34
  start-page: 253
  issue: 3
  year: 2010
  ident: e_1_2_12_22_1
  article-title: Therapeutic effect of the recombinant human epidermal growth factor (rhEGF) in pressure ulcer
  publication-title: Journal of the Korean Academy of Rehabilitation Medicine
– ident: e_1_2_12_7_1
  doi: 10.1016/S0092-8674(02)00963-7
– ident: e_1_2_12_37_1
  doi: 10.3390/cancers12113120
– ident: e_1_2_12_18_1
  doi: 10.1111/j.1742-481X.2011.00895.x
– ident: e_1_2_12_67_1
  doi: 10.3390/medicina57020166
– ident: e_1_2_12_41_1
  doi: 10.5021/ad.2018.30.1.54
– ident: e_1_2_12_4_1
  doi: 10.1177/1534734616645444
– ident: e_1_2_12_6_1
  doi: 10.2174/1389201023378229
– ident: e_1_2_12_60_1
  doi: 10.1111/jocd.12855
– ident: e_1_2_12_45_1
  doi: 10.1111/j.1524-4725.2006.32354.x
– ident: e_1_2_12_34_1
  doi: 10.7314/APJCP.2013.14.8.4859
– ident: e_1_2_12_35_1
  doi: 10.3857/roj.2014.32.3.156
– ident: e_1_2_12_32_1
  doi: 10.1269/jrr.09066
– ident: e_1_2_12_56_1
  doi: 10.1242/dev.031427
– ident: e_1_2_12_66_1
  doi: 10.1097/DSS.0000000000000197
– ident: e_1_2_12_36_1
  doi: 10.1038/nrc1970
– ident: e_1_2_12_3_1
  doi: 10.1172/JCI116130
– ident: e_1_2_12_10_1
  doi: 10.3390/ph13080167
– ident: e_1_2_12_21_1
  doi: 10.4103/0976-9668.136160
– ident: e_1_2_12_11_1
  doi: 10.1007/s00403-014-1463-9
– ident: e_1_2_12_29_1
  doi: 10.1016/j.tjog.2021.03.014
– ident: e_1_2_12_68_1
  doi: 10.1111/jocd.12691
– ident: e_1_2_12_13_1
  doi: 10.4172/2157-2518.1000115
– ident: e_1_2_12_63_1
  doi: 10.5021/ad.2017.29.2.187
– ident: e_1_2_12_14_1
  doi: 10.1111/j.1742-481X.2009.00622.x
– ident: e_1_2_12_26_1
  doi: 10.1111/j.1524-475X.2010.00612.x
– ident: e_1_2_12_51_1
  doi: 10.1159/000445630
– ident: e_1_2_12_16_1
  doi: 10.4142/jvs.2006.7.2.105
– volume: 16
  start-page: 322
  issue: 4
  year: 2017
  ident: e_1_2_12_44_1
  article-title: Improvement of atrophic acne scars in skin of color using topical synthetic epidermal growth factor (EGF) serum: a pilot study
  publication-title: J Drugs Dermatol
– ident: e_1_2_12_38_1
  doi: 10.1634/theoncologist.2019-0221
– ident: e_1_2_12_40_1
  doi: 10.1016/j.jdermsci.2014.04.011
– ident: e_1_2_12_64_1
  doi: 10.5021/ad.2019.31.3.263
– volume: 24
  start-page: 462
  issue: 4
  year: 2010
  ident: e_1_2_12_24_1
  article-title: Clinical study on repair of burn wounds of degree II with recombinant human epidermal growth factor in elderly patients
  publication-title: Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
– ident: e_1_2_12_5_1
  doi: 10.1111/j.1742-481X.2009.00584.x
– ident: e_1_2_12_52_1
  doi: 10.1016/S0925-4773(01)00452-X
– ident: e_1_2_12_2_1
  doi: 10.1016/S0021-9258(19)83739-0
– ident: e_1_2_12_8_1
  doi: 10.1016/j.actbio.2017.11.045
– ident: e_1_2_12_58_1
  doi: 10.1111/exd.12182
– ident: e_1_2_12_47_1
  doi: 10.4049/jimmunol.1301062
– ident: e_1_2_12_49_1
  doi: 10.1155/2018/9439182
– ident: e_1_2_12_54_1
  doi: 10.1074/jbc.M212082200
– ident: e_1_2_12_15_1
  doi: 10.1111/bjd.13954
– ident: e_1_2_12_61_1
  doi: 10.1111/exd.14638
– ident: e_1_2_12_23_1
  doi: 10.1080/09546634.2018.1468546
– ident: e_1_2_12_65_1
  doi: 10.1111/dsu.12348
– ident: e_1_2_12_30_1
  doi: 10.5021/ad.2021.33.6.549
– ident: e_1_2_12_33_1
  doi: 10.1269/jrr.10010
– ident: e_1_2_12_57_1
  doi: 10.4103/ijt.ijt_51_20
– ident: e_1_2_12_46_1
  doi: 10.1159/000521294
– ident: e_1_2_12_9_1
  doi: 10.1016/j.burns.2019.12.015
– ident: e_1_2_12_59_1
  doi: 10.3892/ijmm.2015.2088
– ident: e_1_2_12_48_1
  doi: 10.1038/s41598-018-30404-x
– ident: e_1_2_12_20_1
  doi: 10.1016/j.diabres.2018.06.002
– ident: e_1_2_12_25_1
  doi: 10.1021/acs.biomac.6b01216
– ident: e_1_2_12_50_1
  doi: 10.1111/1523-1747.ep12371760
– volume: 11
  start-page: 613
  issue: 5
  year: 2012
  ident: e_1_2_12_62_1
  article-title: Improved texture and appearance of human facial skin after daily topical application of barley produced, synthetic, human‐like epidermal growth factor (EGF) serum
  publication-title: J Drugs Dermatol
– ident: e_1_2_12_55_1
  doi: 10.1111/exd.12921
SSID ssj0029557
Score 2.5221496
SecondaryResourceType review_article
Snippet Epidermal growth factor (EGF) is a growth factor that plays a pivotal role in wound healing and maintaining tissue homeostasis by regulating cell survival,...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2414
SubjectTerms Acne
Allergens
Cancer therapies
Cell growth
Chemotherapy
Clinical trials
cosmetics
Cytokines
Dermatitis
dermatology
Diabetes
Drug delivery systems
Epidermal growth factor
Erythema
Fibroblasts
Foot diseases
Inflammation
Leg ulcers
Quality of life
Radiation therapy
Review
Scars
Skin
Tumorigenesis
wound
Wound healing
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT4MwFG50XrwYjb_Qaarx4KURKC3lZIxxmUv05OJupLDWLVlgCov_vq_lx7ZMvRFoArxX3vte-_g-hG6YR4WCPEcCphkJAqmJEDwgqccSGjDJ6disQ7688v4wGIzYqF5wK-q2yiYm2kA9zlOzRn5H3cjlkL-Ydz__JEY1yuyu1hIa22jHAyRipBvC0bLgiphl-gTQ7RNDk1IzC5lOnum3CRKuaS9czUcbIHOzV3IVw9ok1NtHezV6xA-Vuw_QlsoOrVI8XhQK5xorI_gKsXaGP6C-Lie40tPB0wzb82UT63Dze9QRGvae3h77pFZFIKlhfiE8DVkaaZXKIBRUQ4bXQroSYEBEE8AziSehhIikDuFjEypJxhwwiMejQPAk9FJ6jDpZnqlTBI8gLF-Z0paFPYx87UO8gxQufarZ2EG3jW3itKYMN8oVs7gpHcCMsTWjg67bofOKJ-O3Qd3GwHH9qRTx0rEOumovwyQ3OxcyU_miiP3QsMj4ocsddFL5o70LtRiKRw4Sa55qBxgC7fUr2XRiibQ9l1IKRSi8p3Xq308eP78P7MHZ_69wjnaNHn3VIdhFnfJroS4AtZTJpZ2aP1fB6bU
  priority: 102
  providerName: ProQuest
Title The use of epidermal growth factor in dermatological practice
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fiwj.14075
https://www.ncbi.nlm.nih.gov/pubmed/36584669
https://www.proquest.com/docview/3090608151
https://www.proquest.com/docview/2759962706
https://pubmed.ncbi.nlm.nih.gov/PMC10333026
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xuPQCVPQRoCu36oFLUBI_I05tWUSRShGCdg9IkZ21y6ooi9iskPj1jJ2H2FKkqpcoiieKXzP-xhl_A_CRp1RZXOdixh2PGdMuVkqwuEy5oYxrQcd-H_LbiTi6YMcjPlqC_e4sTMMP0W-4ec0I9toruDazR0o-ufNqjise2t-UCs-bf3DWU0dlOQ8snwi4s9hTpLSsQj6Kp39zcS16AjCfxkk-xq9hATpch8uu6k3cye-9eW32yvs_WB3_s20bsNYCU_KpmUkvYclWmyEJPZnPLJk6Yn0uWTTj1-QXuu71FWlS9ZBJRcLzujOjpDt59QouDofnX47iNuFCXHpSmViUkpe5s6VmUlGH4MEpnWhEGDk1CJVMqtE7ybWTqMfKGjMWCG9SkTMljExL-hpWqmll3wJWQQUqNOsCwbvMM5ehKUV0oDPq-DiC3a7ri7JlI_dJMa6LzivBPihCH0TwoRe9aSg4_ia0041f0WrhrKBJngjEPDyN4H1fjPrjf4royk7nsyKTnqAmk4mI4E0z3P1XaIBnIo9ALUyEXsBzcy-WVJOrwNGdJpRS9G-xnWGgn6958fXncbjZ-nfRbXjh0943gYg7sFLfzu07BEe1GcByxk7xKkdyAKufhyenZ4Ow0TAI-oHPvv8YDg8eAHefD_o
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED5t5YG9IBAwwgYYBBIvFol_JXlACAFTu6192kTfMie1WaUpLWuriX9qf-PunKTbNOBtb1FsJfbZvvvOPn8H8F4nMnNo57jSXnOlrOdZZhSvEl1Kpa2RE9qHHI5M_1jtj_V4Ay67uzAUVtnpxKCoJ7OK9sg_yTiPDdovnXyZ_-aUNYpOV7sUGs20OHB_LtBlW3wefMfx_SDE3o-jb33eZhXgFTGncFOlusq9q6xKM-nRQvrMxhbNaC5LxANlYhGC59anlLneleXEoA1PTK4yU6ZJJfG7m_BA0REjrp90fO3g5TowiyLIF5xoWVomI4ocml6QUoopnPGm_bsDau_GZt7EzMHo7T2GRy1aZV-b6fUENlz9NGSmZ6uFYzPPHCWYRd1-xn6hP788ZU3-HjatWXi_7HQr665jPYPje5HXc-jVs9q9AGxCFvjRnA-s72kuvED9ipDBCun1JIKPnWyKqqUop0wZZ0XnqqAYiyDGCN6tq84bXo6_VdrtBFy0S3NRXE-kCN6ui3FR0UmJrd1stShESqw1Io1NBNvNeKz_IgNmM3kE2a2RWlcgwu7bJfX0NBB3J7GUEp1e7GcY1H-3vBj83A8PL__fhTfwsH80PCwOB6ODHdgSiMCa6MRd6C3PV-4VIqZl-TpMUwYn970urgAjayUf
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bS8MwFD54AfFFFG_1GsUHXwptc2mKT6KObV7wwaFvJe0SN5BO3IZ_35P0wsYUfCtNStNzyflOmnwH4IKHVGqMcz7jhvuMKeNLKZifhzyjjCtB-3Yd8vFJtHus-8bfluCqPgtT8kM0C27WM9x8bR38s29mnHz4bd0cI94yrDK0O2veEXtusq2EO5pPRNyRbzlSKlohu42neXQ-GC0gzMWNkrMA1kWg1iZsVNCRXJe63oIlXWy7MvFkOtZkZIi21V5xov0g75hcTwakLKZDhgVx9yf1REfqs1E70Gvdvdy0_aokgp9b2hdf5DHPE6NzxWJJDYZ3I1WgEAMkNEMwk4UK84dEmRg9Teos6wsEIKFImBRZHOZ0F1aKUaH3AYcgHVmZNo6CPU4iE-Fkh_FbRdTwvgeXtWzSvOILt2UrPtI6b0Axpk6MHpw3XT9LkozfOh3VAk4rPxmnNEgCgaiEhx6cNc1o4fa3hSr0aDpOo9hSyERxIDzYK_XRvIU6ACUSD-ScppoOlj17vqUYDhyLdhhQSjEDxe90Sv175GnntesuDv7f9RTWnm9b6UPn6f4Q1m2N-nLX4BGsTL6m-hiRzCQ7cRb7A9zd7Jg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+use+of+epidermal+growth+factor+in+dermatological+practice&rft.jtitle=International+wound+journal&rft.au=Shin%2C+Sun+Hye&rft.au=Koh%2C+Young+Gue&rft.au=Lee%2C+Woo+Geon&rft.au=Seok%2C+Joon&rft.date=2023-08-01&rft.issn=1742-481X&rft.eissn=1742-481X&rft.volume=20&rft.issue=6&rft.spage=2414&rft_id=info:doi/10.1111%2Fiwj.14075&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-4801&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-4801&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-4801&client=summon